These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29622300)

  • 21. Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.
    Danner M; Vennedey V; Hiligsmann M; Fauser S; Gross C; Stock S
    Value Health; 2017 Sep; 20(8):1166-1173. PubMed ID: 28964450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.
    Mühlbacher AC; Bridges JF; Bethge S; Dintsios CM; Schwalm A; Gerber-Grote A; Nübling M
    Eur J Health Econ; 2017 Mar; 18(2):155-165. PubMed ID: 26846922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.
    Schatz NK; Fabiano GA; Cunningham CE; dosReis S; Waschbusch DA; Jerome S; Lupas K; Morris KL
    Patient; 2015 Dec; 8(6):483-97. PubMed ID: 25644223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient preferences for treatment of low back pain-a discrete choice experiment.
    Kløjgaard ME; Manniche C; Pedersen LB; Bech M; Søgaard R
    Value Health; 2014 Jun; 17(4):390-6. PubMed ID: 24968999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What Influences Patients' Decisions When Choosing a Health Care Provider? Measuring Preferences of Patients with Knee Arthrosis, Chronic Depression, or Alzheimer's Disease, Using Discrete Choice Experiments.
    Groenewoud S; Van Exel NJ; Bobinac A; Berg M; Huijsman R; Stolk EA
    Health Serv Res; 2015 Dec; 50(6):1941-72. PubMed ID: 26768957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review Comparing the Acceptability, Validity and Concordance of Discrete Choice Experiments and Best-Worst Scaling for Eliciting Preferences in Healthcare.
    Whitty JA; Oliveira Gonçalves AS
    Patient; 2018 Jun; 11(3):301-317. PubMed ID: 29177797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scale Heterogeneity in Healthcare Discrete Choice Experiments: A Primer.
    Vass CM; Wright S; Burton M; Payne K
    Patient; 2018 Apr; 11(2):167-173. PubMed ID: 29032437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating patient-preference evidence into regulatory decision making.
    Ho MP; Gonzalez JM; Lerner HP; Neuland CY; Whang JM; McMurry-Heath M; Hauber AB; Irony T
    Surg Endosc; 2015 Oct; 29(10):2984-93. PubMed ID: 25552232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
    Vass CM; Rigby D; Payne K
    Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes.
    Hauber AB; Nguyen H; Posner J; Kalsekar I; Ruggles J
    Curr Med Res Opin; 2016; 32(2):251-62. PubMed ID: 26549576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers.
    Morel T; Aymé S; Cassiman D; Simoens S; Morgan M; Vandebroek M
    Orphanet J Rare Dis; 2016 May; 11(1):70. PubMed ID: 27225337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Guide to Measuring and Interpreting Attribute Importance.
    Gonzalez JM
    Patient; 2019 Jun; 12(3):287-295. PubMed ID: 30906968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduce mortality risk above all else: a discrete-choice experiment in acute coronary syndrome patients.
    Mühlbacher AC; Bethge S
    Pharmacoeconomics; 2015 Jan; 33(1):71-81. PubMed ID: 25342231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrete choice experiments of pharmacy services: a systematic review.
    Vass C; Gray E; Payne K
    Int J Clin Pharm; 2016 Jun; 38(3):620-30. PubMed ID: 26610687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients' preferences in anticoagulant therapy: discrete choice experiment.
    Najafzadeh M; Gagne JJ; Choudhry NK; Polinski JM; Avorn J; Schneeweiss SS
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):912-9. PubMed ID: 25387782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Best-worst scaling vs. discrete choice experiments: an empirical comparison using social care data.
    Potoglou D; Burge P; Flynn T; Netten A; Malley J; Forder J; Brazier JE
    Soc Sci Med; 2011 May; 72(10):1717-27. PubMed ID: 21530040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for measuring patient preferences: an update and future directions.
    Meara A; Crossnohere NL; Bridges JFP
    Curr Opin Rheumatol; 2019 Mar; 31(2):125-131. PubMed ID: 30624283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring how individuals complete the choice tasks in a discrete choice experiment: an interview study.
    Veldwijk J; Determann D; Lambooij MS; van Til JA; Korfage IJ; de Bekker-Grob EW; de Wit GA
    BMC Med Res Methodol; 2016 Apr; 16():45. PubMed ID: 27098746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
    Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
    Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.